Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 39 for “"MECP2 gene"”.

  1. Investigating the transcriptional control of the MECP2 gene by using a newly developed cell line

    … the discovery of Methyl CpG binding protein 2 (MeCP2) as a reader of DNA methylation in the brain. If this role is impaired in neurons, as is seen in individuals diagnosed with Rett Syndrome (RTT), severe mental disability ensues. A contributing factor to this level of severity could be …

    manitoba Repository record for Investigating the transcriptional control of the MECP2 gene by using a newly developed cell line (opens in a new tab)

  2. Κλινική και μοριακή ανάλυση του γονιδίου MECP2 του συνδρόμου Rett σε παιδιά με νοητική υστέρηση στον ελληνικό πληθυσμό

    Mutations in the MECP2 gene (methyl-CpG-binding protein-2) are responsible for 60-95% of cases of Rett syndrome (RTT), an X-linked dominant neurodevelopmental disorder affecting mostly girls. Classic RTT is characterized by normal early development, followed by psychomotor regression and onset of …

    greece Repository record for Κλινική και μοριακή ανάλυση του γονιδίου MECP2 του συνδρόμου Rett σε παιδιά με νοητική υστέρηση στον ελληνικό πληθυσμό (opens in a new tab)

  3. Heat Shock Factor 1 Signaling: A Novel Pathway Implicated in Rett Syndrome Pathophysiology

    … mutations in the methyl-CPG binding protein 2 (MECP2) gene. There are limited therapeutic options to address the wide range of social, cognitive, motor, and respiratory symptoms that patients experience throughout their lifetime. To identify novel therapeutic targets, we leveraged a rare form of …

    loyola-thes Repository record for Heat Shock Factor 1 Signaling: A Novel Pathway Implicated in Rett Syndrome Pathophysiology (opens in a new tab)

  4. A pre-clinical study of a therapy for Rett Syndrome by using a relevant transgenic mouse model

    … mutations in the Methyl CpG Binding Protein 2 (MECP2) gene, which codes the MeCP2 protein are the underlying cause of over 95 % of RTT cases. MeCP2 is an epigenetic reader of methylated DNA, which controls gene expression in various cell types of the brain, mainly neurons. The control of MECP2 …

    manitoba Repository record for A pre-clinical study of a therapy for Rett Syndrome by using a relevant transgenic mouse model (opens in a new tab)

  5. A comparative characterization of methyl-CpG binding protein 2 isoforms in the developing and adult mouse brain

    Methyl-CpG binding protein 2 (MeCP2) is an epigenetic regulator in brain that binds to both methylated and hyroxymethylated DNA with similar affinities. MeCP2 has two isoforms, MeCP2E1 and MeCP2E2 with distinct N-terminus. These isoforms are generated by alternative splicing of the MECP2/Mecp2 …

    manitoba Repository record for A comparative characterization of methyl-CpG binding protein 2 isoforms in the developing and adult mouse brain (opens in a new tab)

  6. INVESTIGATING THE ROLE OF CHOLINE AS A NUTRACEUTICAL FOR RETT SYNDROME

    … mutations in the methyl-CpG-binding protein 2 (MECP2) gene. Choline, a dietary micronutrient, has been reported to enhance motoric function in RTT mouse models. However, its exact mechanism of action is unknown. In this study, postnatal choline treatment to Mecp2-conditional knockout mice …

    nus Repository record for INVESTIGATING THE ROLE OF CHOLINE AS A NUTRACEUTICAL FOR RETT SYNDROME (opens in a new tab) Download file for INVESTIGATING THE ROLE OF CHOLINE AS A NUTRACEUTICAL FOR RETT SYNDROME (opens in a new tab)

  7. Developing novel therapeutic strategies for Rett syndrome

    … is caused by de novo mutations in the X-linked gene MECP2. There are currently no treatments, but genetic studies in mice have shown that the disease is reversible, even after the onset of symptoms. Since there remains a fundamental lack of knowledge about the downstream pathways involved in …

    glasgow Download PDF for Developing novel therapeutic strategies for Rett syndrome (opens in a new tab)

  8. Astrocyte Morphology and Cell Number in Rett Syndrome

    … regulator methyl CPG binding protein 2 (MECP2) gene that affects 1 in 10,000 female live births annually. RTT patients experience seemingly normal development for the first 12-18 months of life; this period of normal development is followed by developmental regression. The symptoms of …

    uab Repository record for Astrocyte Morphology and Cell Number in Rett Syndrome (opens in a new tab)

  9. An investigation of respiratory abnormalities in a male and female mouse model of Rett Syndrome

    … by loss-of-function mutations in the human MECP2 gene. It remains unknown as to whether the respiratory abnormalities seen in RTT patients and MeCP2 deficient animals may be due to problems with respiratory rhythmogenesis or the result of an inappropriate chemosensitive response. The main …

    glasgow Download PDF for An investigation of respiratory abnormalities in a male and female mouse model of Rett Syndrome (opens in a new tab)

  10. Developmental Regression Analysis and Investigation of Genotype Correlations in Individuals With Classic Rett Syndrome

    … RTT is caused by pathogenic variants in the MECP2 gene and is characterized by developmental regression, stereotypical hand movements, and an abnormal gait. Despite consistency in the presence of these core features, a wide range of features and varying severity can be observed in girls with …

    south-carolina Repository record for Developmental Regression Analysis and Investigation of Genotype Correlations in Individuals With Classic Rett Syndrome (opens in a new tab)

  11. Investigating the sex- and developmental-dependent molecular and gross characterization of the brain of two mouse models of Rett Syndrome

    Methyl-CpG-binding protein 2 (MeCP2) is a multifunctional protein involved in neurogenesis, synaptogenesis, and activity-dependent gene expression in the brain. Mutations in the MECP2 gene are responsible for Rett Syndrome (RTT), a debilitating neurodevelopmental genetic disorder which primary …

    manitoba Repository record for Investigating the sex- and developmental-dependent molecular and gross characterization of the brain of two mouse models of Rett Syndrome (opens in a new tab)

  12. Exploring induced secondary structure and unmethylated DNA binding domains of methyl CpG binding protein 2 (MeCP2)

    … understanding of Methyl CpG binding protein 2 (MeCP2) structure and function has changed and expanded considerably over the last two decades. Mutations along the entirety of the human MeCP2 gene product lead to a disease state - Rett syndrome. The clinical connection of this protein has …

    colostate Repository record for Exploring induced secondary structure and unmethylated DNA binding domains of methyl CpG binding protein 2 (MeCP2) (opens in a new tab)

  13. Studies of Mitochondrial Dysfunction in Models of Rett Syndrome

    … that is predominantly caused by mutations in the MECP2 gene. RTT is characterized by a loss of previously acquired skills, ambulatory deficits, respiratory problems and overall retarded growth. Mitochondrial dysfunction and oxidative stress identified in MeCP2-deficient tissues raised the …

    toronto-retro Repository record for Studies of Mitochondrial Dysfunction in Models of Rett Syndrome (opens in a new tab)

  14. Rescuing Rett-Like Phenotype in Mice by Ablation of Sirt3 and Trpm2

    Rett syndrome, a genetic postnatal neurodevelopmental disorder, presents with developmental delay, motor dysfunction, autism-like behaviour, and seizures, affecting ~1 in 10,000 live births, primarily in females. Mutations in the X-linked methyl CpG binding protein 2 (MECP2) gene account for 90% of …

    toronto-retro Repository record for Rescuing Rett-Like Phenotype in Mice by Ablation of Sirt3 and Trpm2 (opens in a new tab)

  15. Identification of the affected pathways in post-mortem human Rett Syndrome brain tissues using transcriptomic analysis and preclinical evaluation of simvastatin in transgenic mice

    … from loss-of-function mutations in the MECP2 gene. MeCP2 functions as an epigenetic regulator of gene expression, and its dysfunction leads to widespread transcriptional abnormalities. However, the precise molecular pathways impacted in human RTT brain tissue are still not fully …

    manitoba Repository record for Identification of the affected pathways in post-mortem human Rett Syndrome brain tissues using transcriptomic analysis and preclinical evaluation of simvastatin in transgenic mice (opens in a new tab)

  16. Examining Parental Disclosure to Unaffected Siblings of Children Diagnosed With Rett Syndrome

    … manner due to pathogenic variants in the MECP2 gene that are almost always de novo. It is one of the most common causes of developmental delay and intellectual disability in females and occurs in about 1 in 10,000 females. While there is valuable literature surrounding the impact of a …

    south-carolina Repository record for Examining Parental Disclosure to Unaffected Siblings of Children Diagnosed With Rett Syndrome (opens in a new tab)

  17. Genetic, Functional and Clinical Evaluation of MeCP2 Mutations

    … disorder, the second most common genetic cause of intellectual disability (ID) in girls. Rett incidence (1:10,000-15,000) accounts for 2-3% of all cases of severe ID of genetic origin and 10% of the cases of profound ID in females. RTT is caused by mutations in the X-linked Methyl …

    toronto-retro Repository record for Genetic, Functional and Clinical Evaluation of MeCP2 Mutations (opens in a new tab)

  18. Dose-dependent effects of metformin on the phenotypic and behavioral characteristics of a transgenic mouse model of Rett Syndrome with MeCP2 non-sense mutation

    Background/ Introduction: Epigenetic mechanisms control brain development. Such mechanisms include DNA methylation with key roles in neuronal maturation. Methyl CpG Binding Protein (MeCP2) is the main protein that binds the methylated DNA in the brain. Mutations in the MECP2 gene cause changes in …

    manitoba Repository record for Dose-dependent effects of metformin on the phenotypic and behavioral characteristics of a transgenic mouse model of Rett Syndrome with MeCP2 non-sense mutation (opens in a new tab)

  19. Investigating transcriptional control of MECP2-BDNF-miR-132 homeostasis network; implicating the role of MeCP2E1/E2 overexpression and metabolic drugs

    Rett Syndrome (RTT) and MECP2 Duplication Syndrome (MDS) are caused by mutations in the MECP2 gene encoding “methyl CpG binding protein 2” (MeCP2), a critical epigenetic regulator in the brain. There is no cure available for these diseases, but symptoms have been reversed in mouse models. The two …

    manitoba Repository record for Investigating transcriptional control of MECP2-BDNF-miR-132 homeostasis network; implicating the role of MeCP2E1/E2 overexpression and metabolic drugs (opens in a new tab)

  20. Impaired Tunability of Brain State and Motor Dysfunction in a Mouse Model of Rett Syndrome

    … disorder, caused by disrupted function of the MECP2 gene, resulting in impaired cognitive and motor functions. Previous studies suggest that although MECP2 has important functions throughout the body, the etiological origins of RTT-related dysfunction should be sought within the brain. However, …

    arkansas Repository record for Impaired Tunability of Brain State and Motor Dysfunction in a Mouse Model of Rett Syndrome (opens in a new tab)

Page 1 of 2